OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study
Palak Choksi, Maria Papaleontiou, Cui Guo, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 4, pp. 1254-1260
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Sébastiano Filetti, Cosimo Durante, Dana M. Hartl, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1856-1883
Open Access | Times Cited: 889

2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola, Rossella Elisei, Dagmar Führer, et al.
European Thyroid Journal (2019) Vol. 8, Iss. 5, pp. 227-245
Open Access | Times Cited: 240

Bone metastases in thyroid cancer
Nicole M. Iñiguez‐Ariza, Keith C. Bible, B.L. Clarke
Journal of bone oncology (2020) Vol. 21, pp. 100282-100282
Open Access | Times Cited: 90

Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer
Wencai Liu, Zhiqiang Li, Zhiwen Luo, et al.
Cancer Medicine (2021) Vol. 10, Iss. 8, pp. 2802-2811
Open Access | Times Cited: 56

Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues
Alice Nervo, Alberto Ragni, Francesca Retta, et al.
Journal of Endocrinological Investigation (2020) Vol. 44, Iss. 3, pp. 403-419
Open Access | Times Cited: 54

Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
Viktoria Florentine Koehler, Pia Adam, Karin Frank‐Raue, et al.
Thyroid (2020) Vol. 31, Iss. 3, pp. 459-469
Closed Access | Times Cited: 50

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
Nan Sethakorn, Erika Héninger, Cristina Sánchez‐de‐Diego, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 757-757
Open Access | Times Cited: 20

Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result–based analysis
Qing Xue, Wenqiang Che, Lujiadai Xue, et al.
Cancer Medicine (2023) Vol. 12, Iss. 9, pp. 10917-10930
Open Access | Times Cited: 12

Disease-specific mortality of differentiated thyroid cancer with distant metastases
Ali Howaidi, Anwar Ali Alswailem, Abdulrhman Jaber Hakami, et al.
Journal of the Endocrine Society (2025) Vol. 9, Iss. 4
Open Access

The Association Between Lymph Node Stage and Clinical Prognosis in Thyroid Cancer
Junyi Zhang, Xiaoyun Cheng, Lei Shen, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 24

Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study
Chenyuan Li, Qi Wu, Shengrong Sun
Cancer Control (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 23

Familial Hyperparathyroidism – Disorders of Growth and Secretion in Hormone-Secretory Tissue
Stephen J. Marx, Delmar Muniz Lourenço
Hormone and Metabolic Research (2017) Vol. 49, Iss. 11, pp. 805-815
Closed Access | Times Cited: 24

Bone Metastases from Thyroid Carcinoma of Follicular Origin: A Single Institutional Experience
Cláudia Matta-Coelho, Joana Simões‐Pereira, Helena Vilar, et al.
European Thyroid Journal (2018) Vol. 8, Iss. 2, pp. 96-101
Open Access | Times Cited: 21

Skeletal health in patients with differentiated thyroid carcinoma
Miriam Cellini, Mario Rotondi, Maria Laura Tanda, et al.
Journal of Endocrinological Investigation (2020) Vol. 44, Iss. 3, pp. 431-442
Closed Access | Times Cited: 19

Prognostic factors of patients with thyroid cancer and bone metastasis at presentation
Zhaonong Yao, Yuhong Yao, Xiaowei Zhou, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2

Novel nomogram to predict risk of bone metastasis in newly diagnosed thyroid carcinoma: a population-based study
Yuexin Tong, Chuan Hu, Zhangheng Huang, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 17

Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology
Theresa Vogel, Julia Wendler, Karin Frank‐Raue, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 6, pp. e2239-e2246
Open Access | Times Cited: 16

RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Désirèe Deandreis, Aline Maillard, Slimane Zerdoud, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 10, pp. 3238-3249
Open Access | Times Cited: 13

Personalized treatment for differentiated thyroid cancer: current data and new perspectives
Carla Colombo, Noemi Giancola, Laura Fugazzola
Minerva Endocrinology (2021) Vol. 46, Iss. 1
Closed Access | Times Cited: 13

Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma
Maxime Barat, Lambros Tselikas, Thierry de Baère, et al.
European Journal of Radiology (2019) Vol. 119, pp. 108650-108650
Open Access | Times Cited: 15

Comparison of 18F-NaF PET/CT with Other Imaging Methods in the Detection of Bone Metastases in Patients with Medullary Thyroid Cancer: a Report of a Series of 31 Cases
Cristina Emiko Ueda, Paulo Schiavom Duarte, Luciana Audi Castroneves, et al.
Nuclear Medicine and Molecular Imaging (2020) Vol. 54, Iss. 6, pp. 281-291
Open Access | Times Cited: 14

Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma
Xinyun Zhang, Jian-Wen Sun, Zhong‐Ling Qiu, et al.
Endocrine (2019) Vol. 66, Iss. 2, pp. 254-265
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top